Loading institutional data...
Loading institutional data...
Held by 788 of 5,944 reporting institutions (98th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $208.04 today, the market must believe free cash flow compounds 12.4%/yr for a decade (off $788M normalized FCF).
The market's 12.4% is more conservative than its 9-yr track record.
2-stage DCF · 0.10B shares · net debt $1.9B
mean 17.6% · volatility σ 19% · implied rate exceeded in 6/9 yrs
Central path = implied 12.4%/yr growth; shaded band = ±1σ (19%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.20T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.02T | 49.6× | — | 15.7× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $916.2B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $643.4B | 24.2× | — | 6.8× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $464.4B | 111.2× | 33.2× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $362.6B | 19.9× | — | 5.6× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $340.0B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $252.6B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $244.5B | 36.5× | 31.5× | 5.5× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $202.8B | 26.4× | 17.4× | 5.5× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $183.3B | 21.8× | 20.0× | 6.2× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.2B | 27.5× | 19.3× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $156.1B | 20.2× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $147.3B | 41.3× | 30.5× | 6.0× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $135.8B | 48.6× | 37.3× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $130.4B | 33.5× | 28.6× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $129.4B | 18.4× | — | 2.7× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.5B | 24.8× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| LGVN | $117.4B | — | — | 97924.4× | -49.9% | 67.0% | -1894% | -400% | -400% | — | 31 |
| CVS | $116.6B | 66.0× | 11.7× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $108.8B | 33.9× | 18.7× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $103.4B | 23.1× | 16.3× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.7B | 15.2× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.1B | 16.4× | 15.4× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $81.0B | 18.7× | 19.4× | 5.7× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| STE | $20.5B | 26.5× | 14.1× | 3.5× | 8.7% | 44.2% | 13.2% | 10.9% | 8.6% | 1.2× | 788 |
Peers = companies sharing STE's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 25% of free cash flow, leaving room to grow it and fund buybacks. Last year: $242M dividends + $236M buybacks = $477M returned on $972M FCF.
9 consecutive years of dividend increases · 10%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 9%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
$0 of principal comes due within a year. Scheduled principal only (excludes interest & revolver draws). As of 2021-12-31 (10-Q).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~3.1% on $1.9B of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
No material risks flagged.
Where each multiple sits in its own 10-yr range · 15th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 10-yr history.
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
Returns are margin-driven, not leverage-driven — higher quality.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 3.1× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 57.8 | 56.5 | 56.8 | 55.4 | 56.3 | 56.8 | 56.0 | 55.8 |
| Gross Profit | 42.2 | 43.6 | 43.2 | 44.6 | 43.7 | 43.2 | 44.0 | 44.2 |
| R&D | 2.3 | 2.2 | 2.1 | 2.1 | 2.2 | 2.0 | 2.0 | 1.9 |
| SG&A | 24.1 | 23.6 | 23.5 | 31.2 | 24.0 | 24.4 | 24.4 | 23.7 |
| Operating Income | 14.8 | 17.7 | 17.6 | 11.3 | 17.4 | 16.3 | 15.9 | 18.6 |
| Income Tax | 2.3 | 3.0 | 3.9 | 1.9 | 2.7 | 2.9 | 3.4 | 4.4 |
| Net Income | 10.9 | 13.5 | 12.8 | 5.8 | 2.4 | 7.4 | 11.3 | 13.2 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on STE: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2026
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.94B 100.0% | $5.46B 100.0% | $5.14B 100.0% | $4.54B 100.0% | $4.22B 100.0% | $3.11B 100.0% | $3.03B 100.0% | $2.78B 100.0% | $2.62B 100.0% | $2.61B 100.0% |
| Cost of Revenue | $3.31B 55.8% | $3.06B 56.0% | $2.92B 56.8% | $2.56B 56.3% | $2.34B 55.4% | $1.76B 56.8% | $1.71B 56.5% | $1.61B 57.8% | $1.53B 58.3% | $1.59B 60.7% |
| Gross Profit | $2.63B 44.2% | $2.40B 44.0% | $2.22B 43.2% | $1.98B 43.7% | $1.88B 44.6% | $1.34B 43.2% | $1.32B 43.6% | $1.17B 42.2% | $1.09B 41.7% | $1.03B 39.3% |
| Research & Development | $112.9M 1.9% | $107.6M 2.0% | $103.7M 2.0% | $98.5M 2.2% | $86.7M 2.1% | $66.3M 2.1% | $65.5M 2.2% | $63.0M 2.3% | $60.8M 2.3% | $59.4M 2.3% |
| Selling, General & Admin | $1.41B 23.7% | $1.33B 24.4% | $1.25B 24.4% | $1.09B 24.0% | $1.32B 31.2% | $731.3M 23.5% | $716.7M 23.6% | $669.9M 24.1% | $632.0M 24.1% | $682.0M 26.1% |
| Total Operating Expenses | $1.52B 25.7% | $1.54B 28.1% | $1.38B 26.9% | $1.19B 26.2% | $1.41B 33.3% | $794.7M 25.6% | $783.0M 25.8% | $764.0M 27.5% | $692.9M 26.4% | $800.0M 30.6% |
| Operating Income | $1.10B 18.6% | $866.6M 15.9% | $836.1M 16.3% | $791.1M 17.4% | $477.8M 11.3% | $548.4M 17.6% | $537.0M 17.7% | $411.0M 14.8% | $399.9M 15.3% | $226.2M 8.7% |
| Interest Expense | $60.7M 1.0% | $86.3M 1.6% | $144.4M 2.8% | $108.0M 2.4% | $89.5M 2.1% | $37.2M 1.2% | $40.3M 1.3% | $45.0M 1.6% | $50.6M 1.9% | $44.5M 1.7% |
| Other Income (Expense), net | -$54.4M -0.9% | -$70.4M -1.3% | -$133.3M -2.6% | -$110.8M -2.4% | -$111.0M -2.6% | -$30.8M -1.0% | -$38.3M -1.3% | -$42.0M -1.5% | -$44.9M -1.7% | -$41.6M -1.6% |
| Pretax Income | $1.05B 17.6% | $796.2M 14.6% | $702.8M 13.7% | $680.3M 15.0% | $366.8M 8.7% | $517.5M 16.7% | $498.8M 16.5% | $369.0M 13.3% | $355.0M 13.5% | $184.6M 7.1% |
| Income Tax Expense | $262.2M 4.4% | $184.7M 3.4% | $149.5M 2.9% | $124.1M 2.7% | $82.3M 1.9% | $120.7M 3.9% | $90.9M 3.0% | $64.3M 2.3% | $63.4M 2.4% | $74.0M 2.8% |
| Net Income | $782.3M 13.2% | $614.6M 11.3% | $378.2M 7.4% | $107.0M 2.4% | $243.9M 5.8% | $397.4M 12.8% | $407.7M 13.5% | $303.7M 10.9% | $290.9M 11.1% | $110.0M 4.2% |
| Per Share | ||||||||||
| EPS (Basic) | $7.97 | $6.24 | $3.83 | $1.07 | $2.50 | $4.66 | $4.81 | $3.59 | $3.42 | $1.29 |
| EPS (Diluted) | $7.93 | $6.20 | $3.81 | $1.07 | $2.48 | $4.63 | $4.76 | $3.55 | $3.39 | $1.28 |
| Weighted Avg Shares (Basic) | 98.2M | 98.6M | 98.8M | 99.7M | 97.5M | 85.2M | 84.8M | 84.6M | 85.0M | 85.5M |
| Weighted Avg Shares (Diluted) | 98.7M | 99.1M | 99.4M | 100.2M | 98.3M | 85.9M | 85.6M | 85.5M | 85.7M | 86.1M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position